亚太药业(002370) - 2015 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2015 was ¥93,918,692.78, a decrease of 3.96% compared to ¥97,787,029.92 in the same period last year[7] - Net profit attributable to shareholders was ¥14,581,515.94, representing a 3.15% increase from ¥14,136,382.34 year-on-year[7] - The net profit after deducting non-recurring gains and losses was ¥14,561,875.83, which is a 20.29% increase from ¥12,105,594.54 in the previous year[7] - Basic earnings per share increased by 16.67% to ¥0.07 from ¥0.06 in the previous year[7] - The estimated net profit attributable to shareholders for the first half of 2015 is expected to range from 18.02 million to 27.04 million yuan, representing a change of -20.00% to 20.00% compared to the same period last year[18] - The company expects stable production and operations in the next reporting period, with net profit changes expected to be less than 20% compared to the same period last year[18] Cash Flow - The net cash flow from operating activities was ¥121,695.95, a significant decrease of 98.33% compared to ¥7,302,371.31 in the same period last year[7] - Net cash flow from operating activities decreased by 98.33% compared to the same period last year, mainly due to a decrease in cash received from sales and an increase in cash paid for purchases[14] - Investment activities generated a net cash flow increase of 52.35% compared to the same period last year, mainly due to a decrease in cash paid for fixed asset construction[14] Assets and Shareholder Information - Total assets at the end of the reporting period were ¥897,194,565.14, up 5.74% from ¥848,527,462.37 at the end of the previous year[7] - Net assets attributable to shareholders increased by 2.12% to ¥763,193,172.05 from ¥747,314,664.40 at the end of the previous year[7] - The total number of ordinary shareholders at the end of the reporting period was 12,193[10] - Zhejiang Apac Group Co., Ltd. held 35.20% of the shares, with 71,800,000 shares, of which 22,950,000 shares were pledged[10] - The company did not engage in any repurchase transactions during the reporting period[11] Receivables and Prepayments - Accounts receivable increased by 41.38% compared to the beginning of the period, mainly due to the use of bank notes for financing[14] - Prepayments increased by 458.94% compared to the beginning of the period, primarily due to an increase in advance payments for raw materials[14] - Other receivables increased by 46.95% compared to the beginning of the period, mainly due to increased land transfer guarantee deposits by subsidiaries[14] Other Comprehensive Income and Taxes - Other comprehensive income increased by 44.09% compared to the beginning of the period, mainly due to the increase in the stock price of "Zhejiang Zhenyuan" held by the company[14] - The company reported a 31.77% decrease in business tax and additional fees compared to the same period last year, mainly due to a decrease in value-added tax payable[14] Construction and Projects - The company’s construction in progress decreased by 71.19% compared to the beginning of the period, mainly due to the completion of the production line project for freeze-dried powder injections[14]